Product Information

ZITUVIMET XR 50-1,000 MG TABLET is a brand product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $5.0195 per EA under NDC 70710180506. Its NADAC has been published 70 times since Apr 23, 2025.

FDA first approved this application on Jul 18, 2024.

ZITUVIMET XR 50-1,000 MG TABLET

sitagliptin and metformin hydrochloride
$5.0195per EA

Strength

1000; 50 mg/1; mg/1

NDC

70710180506

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA216778

FDA Approved

7/18/2024

On Market Since

10/31/2024

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for ZITUVIMET XR 50-1,000 MG TABLET has been published 70 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$5.0195 per EA
All-time high$5.0613 (May 14, 2025)
All-time low$5.0195 (Aug 19, 2026)
52-week high$5.0416
52-week low$5.0195
Median price$5.0348
Average price$5.0376
Largest weekly change-0.1% (Jul 23, 2025)
Weeks tracked70
Tracking sinceApr 23, 2025

Price History

1W

-0.0%

1M

-0.0%

3M

-0.1%

6M

-0.3%

1Y

-0.4%

3Y

N/A

5Y

N/A

All

-0.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ZITUVIMET XR 50-1,000 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZITUVIMET XR 50-1,000 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $5.0195 per EA (NDC 70710180506), effective Aug 19, 2026.

How has the price of ZITUVIMET XR 50-1,000 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZITUVIMET XR 50-1,000 MG TABLET has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Apr 23, 2025.

What are the highest and lowest recorded NADAC prices for ZITUVIMET XR 50-1,000 MG TABLET?

Since Apr 23, 2025, the NADAC for ZITUVIMET XR 50-1,000 MG TABLET has ranged from a low of $5.0195 (Aug 19, 2026) to a high of $5.0613 (May 14, 2025), with a median of $5.0348 per EA.

Are there cheaper alternatives to ZITUVIMET XR 50-1,000 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ZITUVIMET XR 50-1,000 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ZITUVIMET XR 50-1,000 MG TABLET?

ZITUVIMET XR 50-1,000 MG TABLET (NDC 70710180506) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a brand product.